Aging Increases Susceptibility to Ovarian Cancer Metastasis in Murine Allograft Models and Alters Immune Composition of Peritoneal Adipose Tissue-Reference-Cited by-同舟云学术

Aging Increases Susceptibility to Ovarian Cancer Metastasis in Murine Allograft Models and Alters Immune Composition of Peritoneal Adipose Tissue

Published:2018-06 Issue:6 Volume:20 Page:621-631
ISSN:1476-5586
Container-title:Neoplasia
language:en
Short-container-title:Neoplasia

Author:

Loughran Elizabeth A.,Leonard Annemarie K.,Hilliard Tyvette S.,Phan Ryan C.,Yemc Madeleine G.,Harper Elizabeth,Sheedy Emma,Klymenko Yuliya,Asem Marwa,Liu Yueying,Yang Jing,Johnson Jeff,Tarwater Laura,Shi Zonggao,Leevy Matthew,Ravosa Matthew J.,Stack M. Sharon

Publisher

Elsevier BV

Subject

Cancer Research

Reference49 articles.

1. Ovarian Cancer Development and Metastasis;Lengyel;Am J Pathol,2010

2. Origin and molecular pathogenesis of ovarian high-grade serous carcinoma;Kurman;Ann Oncol,2013

3. Histologic subtypes of ovarian carcinoma: an overview;Soslow;Int J Gynecol Pathol,2008

4. Hematogenous metastasis of ovarian cancer: rethinking mode of spread;Pradeep;Cancer cell,2014

5. New models of hematogenous ovarian cancer metastasis demonstrate preferential spread to the ovary and a requirement for the ovary for abdominal dissemination;Coffman;Transl Res,2016

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Host obesity alters the ovarian tumor immune microenvironment and impacts response to standard of care chemotherapy;Journal of Experimental & Clinical Cancer Research;2023-07-12

2. Advanced Glycation End Products as a Potential Target for Restructuring the Ovarian Cancer Microenvironment: A Pilot Study;International Journal of Molecular Sciences;2023-06-06

3. Mast cells and M2 macrophages in ovarian cancer;Journal of Obstetrics and Gynaecology;2022-07-22

4. Metabolic reprogramming: a bridge between aging and tumorigenesis;Molecular Oncology;2022-06-19

5. Aging accelerates while multiparity delays tumorigenesis in mouse models of high-grade serous carcinoma;Gynecologic Oncology;2022-06